EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study

Tae Jong Jeong, Yiyoung Kwon, Yoon Zi Kim, Eun Sil Kim, Yon Ho Choe, Mi Jin Kim

Digestive and Liver Disease · 2026-12 · 58 (12) · 1562-1568

DOI: 10.1016/j.dld.2026.09.025 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Digestive and Liver Disease, 2026-12. Verfasst von Tae Jong Jeong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Crohn Disease, Infliximab, Gastrointestinal Agents. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Celltrion Pharm Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseInfliximabGastrointestinal AgentsHumansFemaleProspective StudiesMaleAdultInjections, SubcutaneousYoung AdultTreatment Outcome

Stichwörter der Autor:innen

PharmacokineticsTherapeutic drug monitoringTreatment optimization

Substanzen

InfliximabGastrointestinal Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: mijin1217.kim@samsung.com.

Förderung

  • Celltrion Pharm Inc

Zitieren

APA

Jeong, T. J., Kwon, Y., Kim, Y. Z., Kim, E. S., Choe, Y. H., & Kim, M. J. (2026). Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study. Digestive and Liver Disease, 58(12), 1562-1568. https://doi.org/10.1016/j.dld.2026.09.025

Vancouver

Jeong TJ, Kwon Y, Kim YZ, Kim ES, Choe YH, Kim MJ. Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study. Digestive and Liver Disease. 2026;58(12):1562-1568. doi:10.1016/j.dld.2026.09.025

BibTeX
@article{Jeong2026,
  author = {Jeong, Tae Jong and Kwon, Yiyoung and Kim, Yoon Zi and Kim, Eun Sil and Choe, Yon Ho and Kim, Mi Jin},
  title = {Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study},
  journal = {Digestive and Liver Disease},
  year = {2026},
  volume = {58},
  number = {12},
  pages = {1562--1568},
  doi = {10.1016/j.dld.2026.09.025}
}
Kostenlos starten →